Literature DB >> 28449480

Reconstruction of mediastinal vessels for invasive thymoma: a retrospective analysis of 25 cases.

Yifeng Sun1, Chang Gu1, Jianxin Shi1, Wentao Fang1, Qingquan Luo2, Dingzhong Hu1, Shijie Fu1, Xufeng Pan1, Yong Chen1, Yu Yang1, Haitang Yang1, Heng Zhao1, Haiquan Chen1,3.   

Abstract

BACKGROUND: Discuss an appropriate strategy for treatment of invasive thymoma invading adjacent great vessels.
METHODS: A retrospective study on 25 patients with invasive thymoma invading neighboring great vessels was performed. The corresponding data including clinical presentation, operation procedure, adjuvant radio-chemotherapy and follow-up were reviewed.
RESULTS: Twenty of 25 (80%) patients with invasive thymoma underwent complete resection of the tumor along with vessel reconstruction. Intraoperatively, different types of operation were conducted, namely, brachiocephalic vein (BCV)-right atrial appendage (RAA) reconstruction in 11 cases, complex vessel reconstruction (more than one graft) in 1 case and superior vena cava (SVC)-SVC reconstruction in the remaining cases. Ringed polytetrafluoroethylene (PTFE) grafts were used for vessel reconstruction. Postoperatively, three cases suffered from pulmonary infection, and three cases had haemothorax, chylothorax and atelectasis, respectively. Two patients died due to acute respiratory distress syndrome within 90 days after the surgery. Within the remaining patients, 11 cases (44%) experienced a relapse and finally 8 (32%) patients died. Compared to R1 resection group, R0 resection group had a better prognosis (Log-rank P=0.0196). The 3- and 5-year survival rates were 79.6% and 59.1%, with median survival time of 84 months.
CONCLUSIONS: Reconstruction of mediastinal vessels for invasive thymoma is a feasible technology method. Radical resection of the tumor with involved neighboring structures is the key to prolong overall survival for patients suffered from invasive thymoma.

Entities:  

Keywords:  Invasive thymoma; prognosis; vessel reconstruction

Year:  2017        PMID: 28449480      PMCID: PMC5394000          DOI: 10.21037/jtd.2017.03.03

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  29 in total

1.  Bovine jugular vein thrombosis in the Fontan circulation.

Authors:  Paul H Schoof; Arjun D Koch; Mark G Hazekamp; Tjalling W Waterbolk; Tjark Ebels; Robert A Dion
Journal:  J Thorac Cardiovasc Surg       Date:  2002-11       Impact factor: 5.209

2.  Superior vena cava reconstruction using bovine jugular vein conduit.

Authors:  Wei Dong Lü; Feng Lei Yu; Zhong Shi Wu
Journal:  Eur J Cardiothorac Surg       Date:  2007-09-04       Impact factor: 4.191

3.  As originally published in 1990: Superior vena caval reconstruction using autologous pericardium. Updated in 1998.

Authors:  W H Warren; W J Piccione; L P Faber
Journal:  Ann Thorac Surg       Date:  1998-07       Impact factor: 4.330

4.  Superior vena cava obstruction caused by radiation induced venous fibrosis.

Authors:  J W Van Putten; N J Schlosser; Z Vujaskovic; A H Leest; H J Groen
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

5.  Superior vena cava resection with prosthetic replacement for non-small cell lung cancer: long-term results of a multicentric study.

Authors:  Lorenzo Spaggiari; Pascal Thomas; Pierre Magdeleinat; Haruhiko Kondo; Gilles Rollet; Jean Francois Regnard; Ryosuke Tsuchiya; Ugo Pastorino
Journal:  Eur J Cardiothorac Surg       Date:  2002-06       Impact factor: 4.191

6.  Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.

Authors:  Eric A Engels; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

7.  Four-year patency of PTFE grafts after replacement of the superior vena cava and the innominate veins.

Authors:  R Garcia-Rinaldi; J L Zamora; M Torres-Salichs; L Desantos; G D Vaughan
Journal:  Tex Heart Inst J       Date:  1988

8.  Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded.

Authors:  K Yagi; T Hirata; T Fukuse; H Yokomise; K Inui; O Ike; H Mizuno; M Aoki; S Hitomi; H Wada
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

9.  ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.

Authors:  Alexander Marx; Philipp Ströbel; Sunil S Badve; Lara Chalabreysse; John K C Chan; Gang Chen; Laurence de Leval; Frank Detterbeck; Nicolas Girard; Jim Huang; Michael O Kurrer; Libero Lauriola; Mirella Marino; Yoshihiro Matsuno; Thierry Jo Molina; Kiyoshi Mukai; Andrew G Nicholson; Daisuke Nonaka; Ralf Rieker; Juan Rosai; Enrico Ruffini; William D Travis
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

10.  Surgical pathology of the thymus: 20 years' experience.

Authors:  S R Large; J M Shneerson; P G Stovin; J Wallwork
Journal:  Thorax       Date:  1986-01       Impact factor: 9.139

View more
  11 in total

Review 1.  Outcomes of extended surgical resections for locally advanced thymic malignancies: a narrative review.

Authors:  Davide Tosi; Francesco Damarco; Sara Franzi; Shehab Mohamed; Alessandro Palleschi; Paolo Mendogni
Journal:  Gland Surg       Date:  2022-03

2.  Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis.

Authors:  Dazhong Liu; Pengfei Zhang; Jiaying Zhao; Lei Yang; Wei Wang
Journal:  Biomed Res Int       Date:  2021-05-19       Impact factor: 3.411

3.  Invasive thymoma leading to pulmonary artery embolism during operation: A case report.

Authors:  Cheng Fang; Hui Pan; Zhoubin Li; Shuang Lin; Liang Ma; Weili Han
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Extracorporeal membrane oxygenation (ECMO) assisted mediastinal tumor resection and superior vena cava replacement are safe and feasible.

Authors:  Shixin Zhang; Deli Tan; Wei Wu; Bo He; Tao Jing; Meng Tang; Tao Wu; Hongxiang Liu; Ming Zhang; Ni Zhou; Lingfeng Tang; Qiao Chen; Jinghua Tang; Mei Xia; Aihong Huang; Yi Liao; Yang Qiu; Haidong Wang
Journal:  Thorac Cancer       Date:  2019-07-12       Impact factor: 3.500

5.  Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism.

Authors:  Bin Liu; Yang Zhang; Jian Suo
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

6.  Marker Genes Change of Synovial Fibroblasts in Rheumatoid Arthritis Patients.

Authors:  Lifen Liao; Ke Liang; Lan Lan; Jinheng Wang; Jun Guo
Journal:  Biomed Res Int       Date:  2021-06-04       Impact factor: 3.411

7.  Integrative Analysis of Differently Expressed Genes Reveals a 17-Gene Prognosis Signature for Endometrial Carcinoma.

Authors:  Anna Wang; Hongyan Guo; Zaiqiu Long
Journal:  Biomed Res Int       Date:  2021-07-14       Impact factor: 3.411

8.  Total superior vena cava reconstruction guided by preoperative three-dimensional (3D)-computed tomography bronchography and angiography.

Authors:  Zhenyang Zhang; Tianci Chai; Jiangbo Lin; Mingqiang Kang; Wenhua Chen; Hanfan Qiu; Zhiqiang Zou; Lei Gao; Chuangcai Yang; Jiafu Zhu
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

9.  Long Non-coding RNA FIRRE Acts as a miR-520a-3p Sponge to Promote Gallbladder Cancer Progression via Mediating YOD1 Expression.

Authors:  Shuqing Wang; Yang Wang; Shouhua Wang; Huanjun Tong; Zhaohui Tang; Jiandong Wang; Yongjie Zhang; Jingmin Ou; Zhiwei Quan
Journal:  Front Genet       Date:  2021-06-08       Impact factor: 4.599

10.  Altered Gene Expression in the Testis of Infertile Patients with Nonobstructive Azoospermia.

Authors:  Zhiqiang Wang; Zhongjun Ding; Yan Guan; Chunhui Liu; Linjun Wang; Wensheng Shan; Jie Yang
Journal:  Comput Math Methods Med       Date:  2021-06-09       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.